1. Market Research
  2. > Biological Therapy Industry

Gene Therapy Industry, December 2016 Market Reports from Top Publishers

You might be interested in: Therapy, Blood Disease, Tissue Engineering, Cancer, Cell Therapy, Bioinformatics, Biopharmaceutical, Diabetes, Biotechnology, Cell Culture, Eye Disease, Biotech, Clinical Trial, Factor VIII, Graphene, Insulin, Oncology, Pharmaceutical, Point Of Care Testing, Protein Engineering.


 
1-10 of 47 reports for Gene Therapy

Purchase Reports From Reputable Market Research Publishers

Integrase Inhibitors -Pipeline Insights, 2016

Integrase Inhibitors -Pipeline Insights, 2016

  • $ 1250
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “Integrase Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Integrase Inhibitors. The DelveInsight’s ...

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 202

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 202

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global bioinformatics market is projected to reach USD 16.18 billion by 2021 from USD 6.21 billion in 2016, growing at a CAGR of 21.1% during the forecast period. In this report, the bioinformatics ...

Biological Safety Testing Market Analysis By Product (Reagents & Kits, Instruments, Services), By Application (Stem Cell, Tissue & Tissue-Based Products, Gene Therapy, Blood & Blood-Based Products, Vaccines & Therapeutics), By Test, And Segment Forecasts

Biological Safety Testing Market Analysis By Product (Reagents & Kits, Instruments, Services), By Application (Stem Cell, Tissue & Tissue-Based Products, Gene Therapy, Blood & Blood-Based Products, Vaccines & Therapeutics), By Test, And Segment Forecasts

  • $ 4950
  • Industry report
  • October 2016
  • by Grand View Research

The biological safety testing market is expected to reach USD 5.54 billion by 2024, according to a new report by Grand View Research, Inc. The biological safety testing market is primarily driven by exponential ...

Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

  • $ 2995
  • Industry report
  • October 2016
  • by Currentpartnering

The Global Gene Therapy Partnering Agreements 2010-2016 report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. ...

Regenerative Medicine Market: By Therapy (Cell Therapy, Gene Therapy, Others), By Product (Autologous Cell-Based, Allogeneic Cell-Based, Acellular), By Application (Orthopaedic & Musculoskeletal Spine, Dermatology, Others) & By Region-Forecast (2016-2021)

Regenerative Medicine Market: By Therapy (Cell Therapy, Gene Therapy, Others), By Product (Autologous Cell-Based, Allogeneic Cell-Based, Acellular), By Application (Orthopaedic & Musculoskeletal Spine, Dermatology, Others) & By Region-Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Regenerative medicines are capable of restoring the functionality of cells & tissues by treating a patient with laboratory grown cells and tissues. Regenerative medicines are used in a wide range of degenerative ...

Gene Therapy in Oncology Drug Pipeline Update

Gene Therapy in Oncology Drug Pipeline Update

  • $ 3068
  • Company report
  • August 2016
  • by Bioseeker

There are today 125 companies plus partners developing 103 gene therapy drugs in 262 developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated number of ceased drugs ...

Global Ophthalmology Drugs Market to 2022 - Angiogenesis Modulators and Gene Therapies to Boost Overall Revenue within the Forecast Period

Global Ophthalmology Drugs Market to 2022 - Angiogenesis Modulators and Gene Therapies to Boost Overall Revenue within the Forecast Period

  • $ 4995
  • Industry report
  • August 2016
  • by GBI Research

Global Ophthalmology Drugs Market to 2022 - Angiogenesis Modulators and Gene Therapies to Boost Overall Revenue within the Forecast Period Summary Ophthalmology is a therapy area that deals with the diagnosis, ...

Trends in Gene Therapy

Trends in Gene Therapy

  • $ 5000
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

The number of gene therapy products in preclinical to Phase III and beyond stages of development doubled between 2012 and 2015. Additionally, three gene therapy products have received regulatory approval ...

Hemophilia Market Analysis By Type (Hemophilia A, Hemophilia B, Hemophilia C), By Treatment (On-demand, Prophylaxis), By Therapy (Replacement Therapy, Immune Tolerance Induction [ITI]Therapy, Gene Therapy), And Segment Forecasts to 2024

Hemophilia Market Analysis By Type (Hemophilia A, Hemophilia B, Hemophilia C), By Treatment (On-demand, Prophylaxis), By Therapy (Replacement Therapy, Immune Tolerance Induction [ITI]Therapy, Gene Therapy), And Segment Forecasts to 2024

  • $ 4950
  • Industry report
  • July 2016
  • by Grand View Research

Global hemophilia market is expected to reach USD 15.2 billion by 2024, according to a new report by Grand View Research, Inc. Increasing need for diagnosis of the target population in order to initiate ...

Gene Therapy Market: By Development Phase(Phase I, Phase II, Phase III), By Applications(Oncology, Infectious Diseases, Genetic Disorders, Cardiovascular Disorders, Diabetes Mellitus, Neurological Disorders, Others) & Geography-Forecast (2016-2021)

Gene Therapy Market: By Development Phase(Phase I, Phase II, Phase III), By Applications(Oncology, Infectious Diseases, Genetic Disorders, Cardiovascular Disorders, Diabetes Mellitus, Neurological Disorders, Others) & Geography-Forecast (2016-2021)

  • $ 5250
  • Industry report
  • February 2016
  • by Industry ARC

Gene therapy can be defined as the treatment of a disease by modifying, replacing, or supplementing a genetic combination that is absent or abnormal and is responsible for causing causing the disease. ...


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.